Sulaiman Nanji

2.6k total citations
80 papers, 1.6k citations indexed

About

Sulaiman Nanji is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Sulaiman Nanji has authored 80 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 37 papers in Oncology and 25 papers in Hepatology. Recurrent topics in Sulaiman Nanji's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Colorectal Cancer Treatments and Studies (19 papers) and Colorectal Cancer Surgical Treatments (11 papers). Sulaiman Nanji is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Colorectal Cancer Treatments and Studies (19 papers) and Colorectal Cancer Surgical Treatments (11 papers). Sulaiman Nanji collaborates with scholars based in Canada, United States and India. Sulaiman Nanji's co-authors include Christopher M. Booth, A. M. James Shapiro, Xuejiao Wei, Sunil V. Patel, Kelly Brennan, Safiya Karim, Shaila J. Merchant, William J. Mackillop, A. M. James Shapiro and Jonathan R. T. Lakey and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Diabetes.

In The Last Decade

Sulaiman Nanji

77 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sulaiman Nanji Canada	24	742	735	319	294	241	80	1.6k
Klaus Kaczirek Austria	27	983 1.3×	861 1.2×	597 1.9×	406 1.4×	150 0.6×	76	2.1k
Abeezar Sarela United Kingdom	23	911 1.2×	635 0.9×	148 0.5×	689 2.3×	56 0.2×	61	2.0k
Callisia N. Clarke United States	22	404 0.5×	789 1.1×	301 0.9×	385 1.3×	179 0.7×	104	1.5k
David A. Laskow United States	21	753 1.0×	402 0.5×	111 0.3×	249 0.8×	73 0.3×	50	2.1k
Werner Van Steenbergen Belgium	25	1.1k 1.5×	480 0.7×	927 2.9×	604 2.1×	109 0.5×	65	2.0k
Yuzo Umeda Japan	26	1.0k 1.4×	791 1.1×	680 2.1×	368 1.3×	72 0.3×	167	2.0k
Michael E. Lidsky United States	21	883 1.2×	533 0.7×	185 0.6×	600 2.0×	200 0.8×	71	1.6k
P. Kienle Germany	21	845 1.1×	1.0k 1.4×	49 0.2×	359 1.2×	205 0.9×	73	1.7k
George Peros Greece	27	790 1.1×	861 1.2×	33 0.1×	479 1.6×	85 0.4×	76	2.0k
Gerald Langman United Kingdom	15	270 0.4×	369 0.5×	71 0.2×	157 0.5×	73 0.3×	48	918

Countries citing papers authored by Sulaiman Nanji

Since Specialization

Citations

This map shows the geographic impact of Sulaiman Nanji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sulaiman Nanji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sulaiman Nanji more than expected).

Fields of papers citing papers by Sulaiman Nanji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sulaiman Nanji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sulaiman Nanji. The network helps show where Sulaiman Nanji may publish in the future.

Co-authorship network of co-authors of Sulaiman Nanji

This figure shows the co-authorship network connecting the top 25 collaborators of Sulaiman Nanji. A scholar is included among the top collaborators of Sulaiman Nanji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sulaiman Nanji. Sulaiman Nanji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nanji, Sulaiman, T. Peter Kingham, & Olusegun Isaac Alatise. (2025). Confronting the Challenges of Hepatocellular Carcinoma in Sub-Saharan Africa: Opportunities for Progress. JCO Global Oncology. 11(11). e2400645–e2400645.

Flemming, Jennifer A., et al.. (2025). Perioperative risks and risk factors in patients with cirrhosis undergoing abdominal wall hernia repair: A population-level analysis. Surgery. 184. 109447–109447. 1 indexed citations

Nanji, Sulaiman, et al.. (2024). Optimizing the consent process for emergent laparoscopic cholecystectomy using an interactive digital education platform: a randomized control trial. Surgical Endoscopy. 38(5). 2593–2601. 1 indexed citations

Zhang, Lisa, Kelly Brennan, Jennifer A. Flemming, et al.. (2023). Emergency Colorectal Surgery in Those with Cirrhosis: A Population-based Study Assessing Practice Patterns, Outcomes and Predictors of Mortality. Journal of the Canadian Association of Gastroenterology. 7(2). 160–168.

Phelan, Rachel, Wilma M. Hopman, Anthony M.‐H. Ho, et al.. (2022). Plasma bupivacaine levels (total and free/unbound) during epidural infusion in liver resection patients: a prospective, observational study. Regional Anesthesia & Pain Medicine. 47(12). 755–761. 2 indexed citations

Karanicolas, Paul J., Yulia Lin, Stuart A. McCluskey, et al.. (2022). Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trial. BMJ Open. 12(2). e058850–e058850. 1 indexed citations

Hanna, Nader M., Susan B. Brogly, Xuejiao Wei, Christopher M. Booth, & Sulaiman Nanji. (2021). Incidence and Risk Factors of Venous Thromboembolism Following Hepatectomy for Colorectal Metastases: A Population‐Based Retrospective Cohort Study. World Journal of Surgery. 46(1). 180–188. 6 indexed citations

Merchant, Shaila J., Weidong Kong, Bishal Gyawali, et al.. (2020). Effectiveness of Trastuzumab in Routine Clinical Practice: A Population-based Study of Patients with HER-2-positive Oesophageal, Gastroesophageal and Gastric Cancer. Clinical Oncology. 33(3). 202–207. 4 indexed citations

Patel, Sunil V., Lisa Zhang, Xuejiao Wei, et al.. (2020). A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer. Diseases of the Colon & Rectum. 63(3). 336–345. 8 indexed citations

10.

Hanna, Timothy P., Qun Miao, Ken R. Reid, et al.. (2018). Clinical Outcomes After Pulmonary Metastasectomy for Melanoma: A Population-Based Study. The Annals of Thoracic Surgery. 106(6). 1675–1681. 10 indexed citations

11.

Merchant, Shaila J., Susan B. Brogly, Christopher M. Booth, et al.. (2018). Palliative Care is Associated with Reduced Aggressive End-of-Life Care in Patients with Gastrointestinal Cancer. Annals of Surgical Oncology. 25(6). 1478–1487. 44 indexed citations

12.

Rodríguez, Laura, Kelly Brennan, Safiya Karim, et al.. (2018). Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study. Clinical Colorectal Cancer. 17(4). e651–e661. 58 indexed citations

13.

Karim, Safiya, Sulaiman Nanji, Kelly Brennan, C.S. Pramesh, & Christopher M. Booth. (2017). Chemotherapy for resected colorectal cancer pulmonary metastases: Utilization and outcomes in routine clinical practice. European Journal of Surgical Oncology. 43(8). 1481–1487. 9 indexed citations

14.

Nanji, Sulaiman, Melanie E. Tsang, Xuejiao Wei, & Christopher M. Booth. (2016). Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases. European Journal of Surgical Oncology. 43(2). 322–329. 11 indexed citations

15.

Nanji, Sulaiman, Sean P. Cleary, Paul M. Ryan, et al.. (2012). Up-front Hepatic Resection for Metastatic Colorectal Cancer Results in Favorable Long-term Survival. Annals of Surgical Oncology. 20(1). 295–304. 39 indexed citations

16.

Nanji, Sulaiman, Wayne W. Hancock, Bin Luo, et al.. (2006). Costimulation Blockade of Both Inducible Costimulator and CD40 Ligand Induces Dominant Tolerance to Islet Allografts and Prevents Spontaneous Autoimmune Diabetes in the NOD Mouse. Diabetes. 55(1). 27–33. 87 indexed citations

17.

Nanji, Sulaiman. (2006). Costimulation Blockade of Both Inducible Costimulator and CD40 Ligand Induces Dominant Tolerance to Islet Allografts and Prevents Spontaneous Autoimmune Diabetes in the NOD Mouse. Diabetes. 55(1). 27–33. 2 indexed citations

18.

Nanji, Sulaiman & A. M. James Shapiro. (2005). Advances in pancreatic islet transplantation in humans. Diabetes Obesity and Metabolism. 8(1). 15–25. 75 indexed citations

19.

Nanji, Sulaiman, Wayne W. Hancock, Colin C. Anderson, et al.. (2004). Multiple Combination Therapies Involving Blockade of ICOS/B7RP-1 Costimulation Facilitate Long-Term Islet Allograft Survival. American Journal of Transplantation. 4(4). 526–536. 60 indexed citations

20.

Trudel, Suzanne, Sulaiman Nanji, Yong Wan, et al.. (2001). Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study. Leukemia. 15(5). 846–854. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact